U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H6O4
Molecular Weight 154.1201
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GENTISIC ACID

SMILES

OC(=O)C1=CC(O)=CC=C1O

InChI

InChIKey=WXTMDXOMEHJXQO-UHFFFAOYSA-N
InChI=1S/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11)

HIDE SMILES / InChI

Molecular Formula C7H6O4
Molecular Weight 154.1201
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Gentisic acid is an active metabolite of salicylic acid degradation, which possesses a broad spectrum of biological activity, such as anti-inflammatory, antirheumatic and antioxidant properties. The antioxidant activity and radioprotective properties of gentisic acid are exerted by its phenoxyl group. It is also used in cosmetics as a skin-whitening agent for the treatment of skin pigmentary disorders by influencing the synthesis of melanin through inhibition of melanosomal tyrosinase activity Gentisic acid is also a biomarker of Renal Cell Carcinoma.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P14679
Gene ID: 7299.0
Gene Symbol: TYR
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Determination of hydroxyl radical by capillary zone electrophoresis with amperometric detection.
2003-10-17
Different antioxidant effects of polyphenols on lipid peroxidation and hydroxyl radicals in the NADPH-, Fe-ascorbate- and Fe-microsomal systems.
2003-10-01
Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia.
2003-10
Isolation of free phenolic compounds from arboreal leaves by use of the Florisil/C18 system.
2003-10
Ascorbic acid: useful as a buffer agent and radiolytic stabilizer for metalloradiopharmaceuticals.
2003-09-18
Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions.
2003-09-04
Evaluation of the quantitativeness of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using an equimolar mixture of uniform poly(ethylene glycol) oligomers.
2003-09
Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain.
2003-09
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
2003-08-18
Irradiation effects in MALDI, ablation, ion production, and surface modifications. Part II. 2,5-dihydroxybenzoic acid monocrystals.
2003-08
Combined effects of electrostatic and pi-pi stacking interactions: selective binding of nucleotides and aromatic carboxylates by platinum(II)-aromatic ligand complexes.
2003-07-21
Molecular characterization of an inducible gentisate 1,2-dioxygenase gene, xlnE, from Pseudomonas alcaligenes NCIMB 9867.
2003-07-17
Lithium treatment induces a hypersensitive-like response in tobacco.
2003-07
Two-laser infrared and ultraviolet matrix-assisted laser desorption/ionization.
2003-07
Determination of hydroxyl radical by capillary electrophoresis and studies on hydroxyl radical scavenging activities of Chinese herbs.
2003-07
Antibacterial xanthones from Kielmeyera variabilis mart. (Clusiaceae).
2003-06
Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits.
2003-06
Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals.
2003-06
Photosynthetic responses of corn and soybean to foliar application of salicylates.
2003-05
Postischemic hypothermia inhibits the generation of hydroxyl radical following transient forebrain ischemia in rats.
2003-05
Tempol, a novel stable nitroxide, reduces brain damage and free radical production, after acute subdural hematoma in the rat.
2003-04
Comparison of laser desorption and matrix-assisted laser desorption/ionization for ruthenium and osmium trisbipyridine complexes using Fourier transform mass spectrometry.
2003-04
Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
2003-03-21
Fluorinated matrix approach for the characterization of hydrophobic perfluoropolyethers by matrix-assisted laser desorption/ionization time-of-flight MS.
2003-03-15
Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment.
2003-03
Nickel-induced oxidative stress and effect of antioxidants in human lymphocytes.
2003-03
Effects of phenolic acids on human phenolsulfotransferases in relation to their antioxidant activity.
2003-02-26
In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats.
2003-02
Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation.
2003-02
Patterned monolayer/polymer films for analysis of dilute or salt-contaminated protein samples by MALDI-MS.
2003-01-15
Matrix-assisted laser desorption/ionization analysis of lipids and high molecular weight hydrocarbons with lithium 2,5-dihydroxybenzoate matrix.
2003
Sample preparation effects in matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry of partially depolymerised carboxymethyl cellulose.
2003
Some aspects of the stability of ion current in a matrix-assisted laser desorption/ionization source.
2003
Analysis of a bioactive beta-(1 --> 3) polysaccharide (Curdlan) using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2003
Ionic matrices for matrix-assisted laser desorption/ionization time-of-flight detection of DNA oligomers.
2003
Sample depletion of the matrix-assisted laser desorption process monitored using radionuclide detection.
2002-12-15
Internal energy of ions generated by matrix-assisted laser desorption/ionization.
2002-12-15
Laser desorption/ionization time-of-flight mass spectrometry on sol-gel-derived 2,5-dihydroxybenzoic acid film.
2002-11-15
[Analysis of aromatic hydrocarbon catabolic genes in strains isolated from soil in Patagonia].
2002-11-06
Ionization energy reductions in small 2,5-dihydroxybenzoic acid-proline clusters.
2002-11
Matrix-assisted ultraviolet laser-desorption ionization and electrospray-ionization time-of-flight mass spectrometry of sulfated neocarrabiose oligosaccharides.
2002-09-27
Solid phase microextraction with matrix assisted laser desorption/ionization introduction to mass spectrometry and ion mobility spectrometry.
2002-09
Factors governing the solubilization of phosphopeptides retained on ferric NTA IMAC beads and their analysis by MALDI TOFMS.
2002-09
A quantitative model of ultraviolet matrix-assisted laser desorption/ionization.
2002-08
Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels.
2002-08
Anti-HSV-1 activity of synthetic humic acid-like polymers derived from p-diphenolic starting compounds.
2002-07
Rapid analysis of intact phospholipids from whole bacterial cells by matrix-assisted laser desorption/ionization mass spectrometry combined with on-probe sample pretreatment.
2002
Mass spectrometric studies of benzoxazine resorcarenes.
2002
Small angle neutron scattering measurements of synthetic polymer dispersions in matrix-assisted laser desorption/ionization matrixes.
2002
[Determination of salicylic acid and its hydroxylated products using high performance liquid chromatography and fluorescence detection].
2001-03
Patents

Sample Use Guides

in rats
Route of Administration: Transdermal
Antioxidant activity of gentisic acid has been studied using fast chemical kinetics and two in vitro models, namely the isolated rat liver mitochondria (RLM) and the human erythrocytes. The presence of gentisic acid (GA) during irradiation significantly reduced the levels of gamma radiation induced damages to lipids and proteins in RLM. GA efficiently scavenged hydroxyl radical (k = 1.1 × 10(10) dm(3)mol(-1)s(-1)) to produce reducing adduct radical (~76%) and oxidizing phenoxyl radical (~24%). GA has also scavenged organohaloperoxyl radical (k = 9.3 × 10(7) dm(3) mol(-1)s(-1)).
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:54:34 GMT 2025
Edited
by admin
on Mon Mar 31 17:54:34 GMT 2025
Record UNII
VP36V95O3T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GENTISIC ACID
II   INN   MI   WHO-DD  
INN  
Official Name English
2,5-DIHYDROXYBENZOIC ACID
INCI  
INCI  
Preferred Name English
GENTISIC ACID [MI]
Common Name English
NSC-27224
Code English
SALICYLIC ACID, 5-HYDROXY-
Common Name English
GENTISIC ACID [II]
Common Name English
5-HYDROXYSALICYLIC ACID
Systematic Name English
MESALAZINE IMPURITY G [EP IMPURITY]
Common Name English
gentisic acid [INN]
Common Name English
Gentisic acid [WHO-DD]
Common Name English
Classification Tree Code System Code
LOINC 79515-3
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID4060078
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
ChEMBL
CHEMBL2106782
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
FDA UNII
VP36V95O3T
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
PUBCHEM
3469
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
MERCK INDEX
m5703
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY Merck Index
NSC
27224
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
DRUG CENTRAL
3260
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
WIKIPEDIA
GENTISIC ACID
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
SMS_ID
100000084521
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
INN
756
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
DAILYMED
VP36V95O3T
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
MESH
C010925
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-718-5
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
ChEMBL
CHEMBL2107562
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
CHEBI
58044
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
CONCEPT Industrial Aid
EVMPD
SUB07895MIG
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
NCI_THESAURUS
C76714
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
CAS
490-79-9
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
CHEBI
17189
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY
RXCUI
1368641
Created by admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
PRIMARY RxNorm
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
Correction factors: for the calculation of contents, multiply the peak areas by 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY